Current Report Filing (8-k)
April 24 2020 - 5:30PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d)
of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): April 22, 2020
XPRESSPA GROUP, INC.
(Exact Name of Registrant as Specified
in its Charter)
|
Delaware
|
001-34785
|
20-4988129
|
(State or other jurisdiction of
incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
254 West 31st Street, 11th
Floor
New York, New York 10001
(Address of Principal Executive Offices
and Zip Code)
Registrant’s telephone number,
including area code: (646) 525-4319
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
¨
|
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
¨
|
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
¨
|
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
¨
|
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section
12(b) of the Act:
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
|
Common stock, par value $0.01 per share
|
|
XSPA
|
|
The Nasdaq Stock Market
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of
the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
|
|
Item 1.01
|
Entry into a Material Definitive Agreement.
|
As previously disclosed, on July 8, 2019,
XpresSpa Group, Inc. (the “Company”) entered into a securities purchase agreement with Calm.com, Inc. (“Calm”)
pursuant to which the Company agreed to sell (i) an aggregate principal amount of $2,500,000 in 5.00% unsecured convertible Notes
due 2022 (the “Calm Note”), which Calm Note was convertible into shares of Series E Convertible Preferred Stock (the
“Series E Preferred Stock”) and (ii) warrants to purchase 937,500 shares of the Company’s common stock, par value
$0.01 per share (the “Common Stock”), at an exercise price initially equal to $2.00 per share, which was subsequently
reduced to $0.175 per share pursuant to the anti-dilution price protection provision in the Calm Note, which was approved by the
Company’s stockholders on October 2, 2019 and which was triggered in connection with a securities purchase agreement entered
into by the Company and certain purchasers on March 19, 2020. On April 17, 2020, the Company and Calm amended and restated the
Calm Note in order to provide, among other items, that Calm shall not have the right to convert the shares of Series E Preferred
Stock issued in connection with the Calm Note into shares of Common Stock to the extent that such conversion would cause Calm to
beneficially own in excess of the Beneficial Ownership Limitation, initially defined as 4.99% of the number of shares of the Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of the Series
E Preferred Stock.
On April 22, 2020, the Company further
amended and restated the Calm Note, which had been transferred from Calm to B3D, LLC (“B3D”), an existing investor
of the Company, in a private transaction, in order to (i) reflect the transfer of the Calm Note to B3D and (ii) provide for the
conversion of the Calm Note directly into Common Stock instead of into shares of the Company’s Series E Convertible Preferred
Stock (the “AR B3D Note”). Aside from the changes outlined above, the original terms of the Calm Note, including the
underlying conversion price and the number of shares of Common Stock that may ultimately be issued in connection with the Calm
Note, remain in effect and have not been changed.
The AR B3D Note is filed herewith as Exhibit
4.1 and is incorporated herein by reference.
|
|
Item 3.02
|
Unregistered Sales of Equity Securities
|
The description of the AR B3D Note as set
forth under Item 1.01 is incorporated by reference into this Item 3.02.
|
|
Item 3.03
|
Material Modification to Rights of Security Holders.
|
The description of the AR B3D Note as set
forth under Item 1.01 is incorporated by reference into this Item 3.03.
|
|
Item 9.01
|
Financial Statements and Exhibits
|
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
XPRESSPA GROUP, INC.
|
|
|
|
|
|
|
|
Dated: April 24, 2020
|
By:
|
/s/ Douglas Satzman
|
|
|
|
Name:
|
Douglas Satzman
|
|
|
|
Title:
|
Chief Executive Officer
|
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Mar 2024 to Apr 2024
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Apr 2023 to Apr 2024
